Sign in

NCT03988309Completed

STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA

Use of a Multiplexed Molecular Biomarker Test Cxbladder, in Real World Decision Making to Provide Clinical Utility Using a Randomized Design ("STRATA Study")

Source: ClinicalTrials.gov · Last updated 31 May 2025

Brief summary (registry, in English)

To evaluate the clinical utility associated with the integration of Cxbladder into the evaluation of subjects presenting with hematuria for evaluation of urothelial carcinoma (UC) without compromising detection of UC.

Status (registry)
Completed
Study type
Interventional
Enrollment
554 (actual)
First submitted
24 Apr 2019
Start date
11 Sept 2019
Primary completion date
24 Jul 2024
Lead sponsor
Pacific Edge Limited
NCT number
NCT03988309

What you commit to

  • Study type: Interventional
  • Participants enrolled: 554
  • From 11 Sept 2019 to the primary completion date, 24 Jul 2024
  • 12 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior history of bladder malignancy or pelvic radiotherapy. Prior history prostate or renal cell carcinoma within the last 5 years.
  • Prior genitourinary manipulation (flexible or rigid cystoscopy / catheterisation, urethral dilation) in the 14 days before urine collection,

Other

  • Known current pregnancy

Who the study is looking for

  • Patient is undergoing investigation of recent confirmed hematuria, as defined by the AUA/SUFU Guideline (Barocas DA, Boorjian SA, Alvarez RD et al. Microhematuria: AUA/SUFU guideline, J Urol 2020; 204:778) (by either flexible or rigid cystoscopy/TURBT), including hematuria subjects referred due to suspicious/positive imaging, in order to determine the presence of urothelial carcinoma.
  • Able to provide a voided urine sample of the required minimum volume
  • Able to give written consent
  • Able and willing to comply with study requirements
  • Aged 18 years or older

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (12)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
London Health Sciences Centre · Victoria Hospital
Coordinator of this site? Confirm its status
LondonCanadaUnknown status
The prostate centre- Diamond Health care centre
Coordinator of this site? Confirm its status
VancouverCanadaUnknown status
Accellacare
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status
UT Southwestern Medical Center
Coordinator of this site? Confirm its status
DallasUnited StatesUnknown status
Division of urology, Penn State Milton S Hershey Medical Center
Coordinator of this site? Confirm its status
HersheyUnited StatesUnknown status
Institute of Urology, USC Norris Comprehensive Cancer Center
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status
Allina Health Cancer Institute
Coordinator of this site? Confirm its status
MinneapolisUnited StatesUnknown status
University of Minnesota, Department of Urology
Coordinator of this site? Confirm its status
MinneapolisUnited StatesUnknown status
Carolina Urologic Research Center
Coordinator of this site? Confirm its status
Myrtle BeachUnited StatesUnknown status
Department of Urology,Vanderbilt University
Coordinator of this site? Confirm its status
NashvilleUnited StatesUnknown status
UTHSA - Mays Cancer Center
Coordinator of this site? Confirm its status
San AntonioUnited StatesUnknown status
Avant Concierge Urology
Coordinator of this site? Confirm its status
Winter GardenUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.